GPR91 Polyclonal Antibody

    • Catalog No.:YT2035
    • Applications:WB;IF;ELISA
    • Reactivity:Human;Mouse;Rat;Pig
      • Target:
      • GPR91
      • Fields:
      • >>cAMP signaling pathway
      • Gene Name:
      • SUCNR1
      • Protein Name:
      • Succinate receptor 1
      • Human Swiss Prot No:
      • Q9BXA5
      • Mouse Swiss Prot No:
      • Q99MT6
      • Immunogen:
      • The antiserum was produced against synthesized peptide derived from human SUCNR1. AA range:100-149
      • Specificity:
      • GPR91 Polyclonal Antibody detects endogenous levels of GPR91 protein.
      • Formulation:
      • Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
      • Source:
      • Polyclonal, Rabbit,IgG
      • Dilution:
      • WB 1:500 - 1:2000. IF 1:200 - 1:1000. ELISA: 1:10000. Not yet tested in other applications.
      • Purification:
      • The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
      • Concentration:
      • 1 mg/ml
      • Storage Stability:
      • -15°C to -25°C/1 year(Do not lower than -25°C)
      • Other Name:
      • SUCNR1;GPR91;Succinate receptor 1;G-protein coupled receptor 91;P2Y purinoceptor 1-like
      • Observed Band(KD):
      • 38kD
      • Background:
      • This gene encodes a G-protein-coupled receptor for succinate, an intermediate molecule of the citric acid cycle. It is involved in the promotion of hematopoietic progenitor cell development, and it has a potential role in renovascular hypertension which has known correlations to renal failure, diabetes and atherosclerosis. [provided by RefSeq, Oct 2009],
      • Function:
      • function:Receptor for succinate.,similarity:Belongs to the G-protein coupled receptor 1 family.,tissue specificity:Expressed specifically in kidney.,
      • Subcellular Location:
      • Cell membrane ; Multi-pass membrane protein .
      • Expression:
      • Expressed specifically in kidney.
      • Products Images
      • Western blot analysis of lysates from HUVEC and MCF-7 cells, using SUCNR1 Antibody. The lane on the right is blocked with the synthesized peptide.